Spironolactone Tablet, Coated
Product Images NDC 68788-8381

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68788-8381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone Tab Usp 100mg (B68235bb 0940 4810 Bbf4 2a7a0881de68 00)

Spironolactone Tab Usp 100mg (B68235bb 0940 4810 Bbf4 2a7a0881de68 00)
Spironolactone Tab USP 100 mg coated tablet label from Preferred Pharmaceuticals, Inc. The label includes the generic name, strength (100 mg), mentions it is generic for Aldactone, and notes the manufacturer as Oxford Pharmaceuticals, LLC. Additional information includes warnings, storage conditions, and a bilingual (English/Spanish) directions section with blank spaces for dosage instructions. The label features a barcode and a QR code, along with cautionary federal law text regarding drug transfer.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve comparing two groups over 48 months. The graph shows probability on the y-axis and time in months on the x-axis. One curve represents Spironolactone (n=822) and the other represents placebo (n=841), with a log-rank p-value less than 0.001 indicating statistical difference between groups.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a clinical study comparing spironolactone to placebo. The subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin, ACE inhibitor, and beta blocker use. The horizontal axis ranges from 0.2 to 1.4, indicating outcomes favoring spironolactone or placebo.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure of spironolactone depicted as a molecular diagram showing its steroid backbone with attached functional groups, including a lactone ring and a thioacetate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.